Selected research
Industry Research
Bovine Medicine and Vaccines Industry Research Report 2026
Market perspective
The global Bovine Medicine and Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bovine Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bovine Medicine and Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bovine Medicine and Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bovine Medicine and Vaccines include Agrovet, Bayer HealthCare, BIGVET Biotech, Biogenesis Bagó, Boehringer Ingelheim, Brilliant Bio Pharma, BVI, CAHIC and Cavet Bio, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bovine Medicine and Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bovine Medicine and Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bovine Medicine and Vaccines Market by Company
Agrovet
Bayer HealthCare
BIGVET Biotech
Biogenesis Bagó
Boehringer Ingelheim
Brilliant Bio Pharma
BVI
CAHIC
Cavet Bio
CEVA
Indian Immunologicals
LIMOR
ME VAC
MSD Animal Health
Sanofi (Merial)
Shen Lian
Tecon Group
VECOL
VETAL
Jinyu Group
Bovine Medicine and Vaccines Segment by Type
Medicine
Vaccines
Bovine Medicine and Vaccines Segment by Application
Farm
Government
Bovine Medicine and Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bovine Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Medicine and Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bovine Medicine and Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Vaccines
Applications
- Farm
- Government
Companies covered
- Agrovet
- Bayer HealthCare
- BIGVET Biotech
- Biogenesis Bagó
- Boehringer Ingelheim
- Brilliant Bio Pharma
- BVI
- CAHIC
- Cavet Bio
- CEVA
- Indian Immunologicals
- LIMOR
- ME VAC
- MSD Animal Health
- Sanofi (Merial)
- Shen Lian
- Tecon Group
- VECOL
- VETAL
- Jinyu Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bovine Medicine and Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Medicine
- 2.2.3 Vaccines
- 2.3 Bovine Medicine and Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Farm
- 2.3.3 Government
- 2.4 Assumptions and Limitations
3 Bovine Medicine and Vaccines Breakdown Data by Type
- 3.1 Global Bovine Medicine and Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global Bovine Medicine and Vaccines Forecasted Market Size by Type (2027-2032)
4 Bovine Medicine and Vaccines Breakdown Data by Application
- 4.1 Global Bovine Medicine and Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global Bovine Medicine and Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bovine Medicine and Vaccines Market Perspective (2021-2032)
- 5.2 Global Bovine Medicine and Vaccines Growth Trends by Region
- 5.2.1 Global Bovine Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bovine Medicine and Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 Bovine Medicine and Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 Bovine Medicine and Vaccines Market Dynamics
- 5.3.1 Bovine Medicine and Vaccines Industry Trends
- 5.3.2 Bovine Medicine and Vaccines Market Drivers
- 5.3.3 Bovine Medicine and Vaccines Market Challenges
- 5.3.4 Bovine Medicine and Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bovine Medicine and Vaccines Players by Revenue
- 6.1.1 Global Top Bovine Medicine and Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global Bovine Medicine and Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global Bovine Medicine and Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bovine Medicine and Vaccines Head Office and Area Served
- 6.4 Global Bovine Medicine and Vaccines Players, Product Type & Application
- 6.5 Global Bovine Medicine and Vaccines Manufacturers Established Date
- 6.6 Global Bovine Medicine and Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bovine Medicine and Vaccines Market Size (2021-2032)
- 7.2 North America Bovine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bovine Medicine and Vaccines Market Size by Country (2021-2026)
- 7.4 North America Bovine Medicine and Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bovine Medicine and Vaccines Market Size (2021-2032)
- 8.2 Europe Bovine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bovine Medicine and Vaccines Market Size by Country (2021-2026)
- 8.4 Europe Bovine Medicine and Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bovine Medicine and Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific Bovine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bovine Medicine and Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bovine Medicine and Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bovine Medicine and Vaccines Market Size (2021-2032)
- 10.2 South America Bovine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bovine Medicine and Vaccines Market Size by Country (2021-2026)
- 10.4 South America Bovine Medicine and Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bovine Medicine and Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa Bovine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bovine Medicine and Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bovine Medicine and Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Agrovet
- 12.1.1 Agrovet Company Information
- 12.1.2 Agrovet Business Overview
- 12.1.3 Agrovet Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.1.4 Agrovet Bovine Medicine and Vaccines Product Portfolio
- 12.1.5 Agrovet Recent Developments
- 12.2 Bayer HealthCare
- 12.2.1 Bayer HealthCare Company Information
- 12.2.2 Bayer HealthCare Business Overview
- 12.2.3 Bayer HealthCare Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.2.4 Bayer HealthCare Bovine Medicine and Vaccines Product Portfolio
- 12.2.5 Bayer HealthCare Recent Developments
- 12.3 BIGVET Biotech
- 12.3.1 BIGVET Biotech Company Information
- 12.3.2 BIGVET Biotech Business Overview
- 12.3.3 BIGVET Biotech Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.3.4 BIGVET Biotech Bovine Medicine and Vaccines Product Portfolio
- 12.3.5 BIGVET Biotech Recent Developments
- 12.4 Biogenesis Bagó
- 12.4.1 Biogenesis Bagó Company Information
- 12.4.2 Biogenesis Bagó Business Overview
- 12.4.3 Biogenesis Bagó Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.4.4 Biogenesis Bagó Bovine Medicine and Vaccines Product Portfolio
- 12.4.5 Biogenesis Bagó Recent Developments
- 12.5 Boehringer Ingelheim
- 12.5.1 Boehringer Ingelheim Company Information
- 12.5.2 Boehringer Ingelheim Business Overview
- 12.5.3 Boehringer Ingelheim Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.5.4 Boehringer Ingelheim Bovine Medicine and Vaccines Product Portfolio
- 12.5.5 Boehringer Ingelheim Recent Developments
- 12.6 Brilliant Bio Pharma
- 12.6.1 Brilliant Bio Pharma Company Information
- 12.6.2 Brilliant Bio Pharma Business Overview
- 12.6.3 Brilliant Bio Pharma Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.6.4 Brilliant Bio Pharma Bovine Medicine and Vaccines Product Portfolio
- 12.6.5 Brilliant Bio Pharma Recent Developments
- 12.7 BVI
- 12.7.1 BVI Company Information
- 12.7.2 BVI Business Overview
- 12.7.3 BVI Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.7.4 BVI Bovine Medicine and Vaccines Product Portfolio
- 12.7.5 BVI Recent Developments
- 12.8 CAHIC
- 12.8.1 CAHIC Company Information
- 12.8.2 CAHIC Business Overview
- 12.8.3 CAHIC Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.8.4 CAHIC Bovine Medicine and Vaccines Product Portfolio
- 12.8.5 CAHIC Recent Developments
- 12.9 Cavet Bio
- 12.9.1 Cavet Bio Company Information
- 12.9.2 Cavet Bio Business Overview
- 12.9.3 Cavet Bio Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.9.4 Cavet Bio Bovine Medicine and Vaccines Product Portfolio
- 12.9.5 Cavet Bio Recent Developments
- 12.10 CEVA
- 12.10.1 CEVA Company Information
- 12.10.2 CEVA Business Overview
- 12.10.3 CEVA Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.10.4 CEVA Bovine Medicine and Vaccines Product Portfolio
- 12.10.5 CEVA Recent Developments
- 12.11 Indian Immunologicals
- 12.11.1 Indian Immunologicals Company Information
- 12.11.2 Indian Immunologicals Business Overview
- 12.11.3 Indian Immunologicals Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.11.4 Indian Immunologicals Bovine Medicine and Vaccines Product Portfolio
- 12.11.5 Indian Immunologicals Recent Developments
- 12.12 LIMOR
- 12.12.1 LIMOR Company Information
- 12.12.2 LIMOR Business Overview
- 12.12.3 LIMOR Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.12.4 LIMOR Bovine Medicine and Vaccines Product Portfolio
- 12.12.5 LIMOR Recent Developments
- 12.13 ME VAC
- 12.13.1 ME VAC Company Information
- 12.13.2 ME VAC Business Overview
- 12.13.3 ME VAC Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.13.4 ME VAC Bovine Medicine and Vaccines Product Portfolio
- 12.13.5 ME VAC Recent Developments
- 12.14 MSD Animal Health
- 12.14.1 MSD Animal Health Company Information
- 12.14.2 MSD Animal Health Business Overview
- 12.14.3 MSD Animal Health Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.14.4 MSD Animal Health Bovine Medicine and Vaccines Product Portfolio
- 12.14.5 MSD Animal Health Recent Developments
- 12.15 Sanofi (Merial)
- 12.15.1 Sanofi (Merial) Company Information
- 12.15.2 Sanofi (Merial) Business Overview
- 12.15.3 Sanofi (Merial) Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.15.4 Sanofi (Merial) Bovine Medicine and Vaccines Product Portfolio
- 12.15.5 Sanofi (Merial) Recent Developments
- 12.16 Shen Lian
- 12.16.1 Shen Lian Company Information
- 12.16.2 Shen Lian Business Overview
- 12.16.3 Shen Lian Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.16.4 Shen Lian Bovine Medicine and Vaccines Product Portfolio
- 12.16.5 Shen Lian Recent Developments
- 12.17 Tecon Group
- 12.17.1 Tecon Group Company Information
- 12.17.2 Tecon Group Business Overview
- 12.17.3 Tecon Group Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.17.4 Tecon Group Bovine Medicine and Vaccines Product Portfolio
- 12.17.5 Tecon Group Recent Developments
- 12.18 VECOL
- 12.18.1 VECOL Company Information
- 12.18.2 VECOL Business Overview
- 12.18.3 VECOL Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.18.4 VECOL Bovine Medicine and Vaccines Product Portfolio
- 12.18.5 VECOL Recent Developments
- 12.19 VETAL
- 12.19.1 VETAL Company Information
- 12.19.2 VETAL Business Overview
- 12.19.3 VETAL Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.19.4 VETAL Bovine Medicine and Vaccines Product Portfolio
- 12.19.5 VETAL Recent Developments
- 12.20 Jinyu Group
- 12.20.1 Jinyu Group Company Information
- 12.20.2 Jinyu Group Business Overview
- 12.20.3 Jinyu Group Revenue in Bovine Medicine and Vaccines Business (2021-2026)
- 12.20.4 Jinyu Group Bovine Medicine and Vaccines Product Portfolio
- 12.20.5 Jinyu Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst